Literature DB >> 30426243

Multidisciplinary team in head and neck cancer: a management model.

F De Felice1, V Tombolini2, M de Vincentiis3, G Magliulo4, A Greco4, V Valentini3, A Polimeni3.   

Abstract

Nowadays, the multidisciplinary team (MDT) is an essential component for oncologic disease management. Its benefit is also extensively recognized in head and neck cancer (HNC) community, due to tumor rarity and complex treatment. A well-defined MDT management serves as a stable point to define the better strategy and offers a chance to optimize HNC clinical outcomes and patient's quality of life. We explored both mandatory and additional requirements for establishing a high-quality MDT. Then we proposed an example of HNC MDT organization. The aim is to contribute to the best way to systematize HNC care.

Entities:  

Keywords:  Head and neck cancer; Management; Multidisciplinary team; Organization; Quality of life; Requirements

Mesh：

Year:  2018        PMID： 30426243     DOI： 10.1007/s12032-018-1227-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  10 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  Follow-up program in head and neck cancer.

Authors:  Francesca De Felice; Marco de Vincentiis; Valentino Valentini; Daniela Musio; Silvia Mezi; Luigi Lo Mele; Valentina Terenzi; Vittorio D'Aguanno; Andrea Cassoni; Martina Di Brino; Gianluca Tenore; Nadia Bulzonetti; Andrea Battisti; Antonio Greco; Giorgio Pompa; Antonio Minni; Umberto Romeo; Enrico Cortesi; Antonella Polimeni; Vincenzo Tombolini
Journal:  Crit Rev Oncol Hematol       Date:  2017-03-14       Impact factor: 6.312

3.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors:  Farin Kamangar; Graça M Dores; William F Anderson
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.

Authors:  William M Lydiatt; Snehal G Patel; Brian O'Sullivan; Margaret S Brandwein; John A Ridge; Jocelyn C Migliacci; Ashley M Loomis; Jatin P Shah
Journal:  CA Cancer J Clin       Date:  2017-01-27       Impact factor: 508.702

5.  Institutional clinical trial accrual volume and survival of patients with head and neck cancer.

Authors:  Evan J Wuthrick; Qiang Zhang; Mitchell Machtay; David I Rosenthal; Phuc Felix Nguyen-Tan; André Fortin; Craig L Silverman; Adam Raben; Harold E Kim; Eric M Horwitz; Nancy E Read; Jonathan Harris; Qian Wu; Quynh-Thu Le; Maura L Gillison
Journal:  J Clin Oncol       Date:  2014-12-08       Impact factor: 44.544

6.  General practitioners assessment of a structured report on medical decision making by a regional multidisciplinary cancer committee.

Authors:  Nicolas Penel; François Valentin; Sandrine Giscard; Luc Vanseymortier; Régis Beuscart
Journal:  Bull Cancer       Date:  2007-10       Impact factor: 1.276

7.  Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas' Head and Neck Cancer Unit experience.

Authors:  Francesca De Felice; Christopher Thomas; Vinod Patel; Steve Connor; Andriana Michaelidou; Chris Sproat; Jerry Kwok; Mary Burke; Damien Reilly; Mark McGurk; Ricard Simo; Andrew Lyons; Richard Oakley; Jean-Pierre Jeannon; Mary Lei; Teresa Guerrero Urbano
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-01-14

Review 8.  Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations.

Authors:  Francesca De Felice; Marco de Vincentiis; Valentino Valentini; Daniela Musio; Silvia Mezi; Luigi Lo Mele; Marco Della Monaca; Vittorio D'Aguanno; Valentina Terenzi; Martina Di Brino; Edoardo Brauner; Nadia Bulzonetti; Gianluca Tenore; Giulia Pomati; Andrea Cassoni; Mario Tombolini; Andrea Battisti; Antonio Greco; Giorgio Pompa; Antonio Minni; Umberto Romeo; Enrico Cortesi; Antonella Polimeni; Vincenzo Tombolini
Journal:  Crit Rev Oncol Hematol       Date:  2017-10-27       Impact factor: 6.312

9.  Health care delivery for head-and-neck cancer patients in Alberta: a practice guideline.

Authors:  J R Harris; H Lau; B V Surgeoner; N Chua; W Dobrovolsky; J C Dort; E Kalaydjian; M Nesbitt; R A Scrimger; H Seikaly; D Skarsgard; M A Webster
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

Review 10.  Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.

Authors:  Francesca De Felice; Antonella Polimeni; Valentino Valentini; Orlando Brugnoletti; Andrea Cassoni; Antonio Greco; Marco de Vincentiis; Vincenzo Tombolini
Journal:  Neoplasia       Date:  2018-02-12       Impact factor: 5.715
  10 in total
  4 in total

1.  [Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus].

Authors:  Dong-Sheng Zhang; Jia-Wei Zheng; Chen-Ping Zhang; Zhi-Gang Cai; Long-Jiang Li; Gui-Qing Liao; Zheng-Jun Shang; Mo-Yi Sun; Zheng-Xue Han; Wei Shang; Jian Meng; Zhong-Cheng Gong; Sheng-Yun Huang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01

2.  Head and neck cancers: Monitoring quality and reporting outcomes.

Authors:  Madhavi Chilkuri; Venkat Vangaveti; Justin Smith
Journal:  J Med Imaging Radiat Oncol       Date:  2021-12-01       Impact factor: 1.667

Review 3.  Value and Quality of Care in Head and Neck Oncology.

Authors:  Robert P Takes; Gyorgy B Halmos; John A Ridge; Paolo Bossi; Matthias A W Merkx; Alessandra Rinaldo; Alvaro Sanabria; Ludi E Smeele; Antti A Mäkitie; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-07-10       Impact factor: 5.075

Review 4.  Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma.

Authors:  Sjoukje F Oosting; Robert I Haddad
Journal:  Front Oncol       Date:  2019-08-27       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.